AMYLYX PHARMACEUTICALS INC's ticker is and the CUSIP is 03237H101. A total of 83 filers reported holding AMYLYX PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.49 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $38,158,040 | +84786.2% | 2,084,000 | 0.0% | 2.03% | -2.6% |
| Q2 2023 | $44,952 | -26.5% | 2,084,000 | 0.0% | 2.08% | -30.6% |
| Q1 2023 | $61,145 | -99.9% | 2,084,000 | 0.0% | 3.00% | -26.0% |
| Q4 2022 | $77,003,800 | +31.3% | 2,084,000 | 0.0% | 4.06% | +23.0% |
| Q3 2022 | $58,665,000 | +38.5% | 2,084,000 | -5.3% | 3.30% | +22.9% |
| Q2 2022 | $42,372,000 | +49.9% | 2,200,000 | 0.0% | 2.68% | +84.7% |
| Q1 2022 | $28,270,000 | – | 2,200,000 | – | 1.45% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 5,472,033 | $154,038,000 | 4.47% |
| Ghost Tree Capital, LLC | 550,000 | $15,483,000 | 4.35% |
| Ghost Tree Capital, LLC | 500,000 | $14,075,000 | 3.95% |
| Bain Capital Life Sciences Investors, LLC | 1,023,214 | $28,803,000 | 3.44% |
| Boxer Capital, LLC | 2,084,000 | $58,665,000 | 3.30% |
| Alpha Wave Global, LP | 700,635 | $19,723,000 | 2.33% |
| Soleus Capital Management, L.P. | 429,336 | $12,086,000 | 1.64% |
| Ikarian Capital, LLC | 250,000 | $7,037,000 | 1.40% |
| Cormorant Asset Management, LP | 610,000 | $17,172,000 | 1.20% |
| SECTORAL ASSET MANAGEMENT INC | 205,400 | $5,782,000 | 1.14% |